• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Resources
    • Resources Overview
    • Elevated Insights
    • Presentations & Publications
    • Whitepapers
  • Media
    • Media Overview
    • Press Releases
    • Featured News
  • Facilities
  • Careers
  • Contact
  • Search
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact
  • Manufacturing & Discovery Services

    Manufacturing & Discovery Services Overview

    Capabilities & Services
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    Expertise
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
    • Investors

Explore
More

  • Gene Editing
  • Viral and Non-Viral Delivery
  • Messenger RNA (mRNA)
  • Induced Pluripotent Stem Cells (iPSCs)

Induced Pluripotent Stem Cells (iPSCs)

Accelerating the path from iPSC-derived concept to clinic-ready therapeutic.

// Messenger RNA (mRNA)

A Faster Starting Point for iPSC-Derived Therapies

Developing an iPSC-derived therapy from scratch means years of cell line generation, characterization, and optimization before you ever reach process development. Our iPSC platform removes that bottleneck. Partners can license thoroughly characterized, clinical- and commercial-grade iPSC lines and build their programs on a foundation that’s already been de-risked.

Setting a New Standard in iPSCs

We are accelerating the development of iPSC-derived therapeutics. Our next-generation iPSC lines are produced in stroma-free, xeno-free, and serum-free conditions – designed for research, clinical, and commercial use. That means fewer manufacturing risks, fewer regulatory hurdles, and faster timelines from license to IND and beyond.

What partners get access to:

  • Characterized cell lines extensively tested and documented, ready to support regulatory filings.
  • Clinical- and commercial-grade quality manufactured under conditions designed to support the full product lifecycle.
  • Flexible licensing options with cell lines available for use across immunotherapy, regenerative medicine, and other iPSC-derived modalities.
  • Integrated support within ElevateBio’s broader manufacturing and process development ecosystem, so partners can move from licensed cell line to GMP production under one roof.

Built for Immunotherapy and Regenerative Medicine

iPSCs offer the potential to create allogeneic, off-the-shelf therapies at a scale and consistency that autologous approaches can’t match. Our platform is purpose-built for the two areas where that potential is most immediate: immuno-oncology and regenerative medicine. Partners across both fields are using our lines to advance programs that would have taken years longer to develop independently.

Partner with ElevateBio®

Wherever you are in your advanced therapy product lifecycle, we can strengthen and accelerate your development journey with our enabling technologies and unmatched process development and manufacturing capabilities.

Partner with Us

// Work with us

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2026 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • Manufacturing & Discovery Services
  • Technologies
  • Advanced Therapies
  • Partner With Us
  • About
  • Presentations & Publications
  • Elevated Insights
  • Careers
  • Facilities
  • Contact
MENU
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact